China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.

Sümbol: 000999.SZ

SHZ

60.44

CNY

Turuhind täna

19.3562
P/E suhe
0.6713
PEG suhe
59.16B
MRK Cap
0.02%
DIV tootlus

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (000999-SZ) Finantsaruanded

Q: Mis on ettevõtte kasumimarginaal?

Ettevõtte kasumimarginaal on .

Download

Aastane Quarterly

Lineaarne Log

Diagrammil näete China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (000999.SZ) vaikimisi numbreid dünaamikates. Companys revenue näitab keskmist 7144.644 M, mis on 0.131 % gowth. Kogu perioodi keskmine brutokasum on 4165.555 M, mis on 0.128 %. Keskmine brutokasumi suhtarv on 0.556 %. Ettevõtte eelmise aasta tulemuse puhaskasv on 0.165 %, mis on võrdne 0.118 % % keskmiselt kogu ettevõtte ajaloo jooksul.,

Aastane Quarterly

10Y 20Y 30Y 40Y

Bilanss

Sukeldudes China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. fiskaalkäiguteele, täheldame keskmist varade kasvu. See määr on huvitaval kombel , mis kajastab nii ettevõtte kõrg- kui ka madalseisusid. Kui võrrelda kvartalite lõikes, siis kohandub see näitaja 0. Kui vaadata tagasi möödunud aastale, siis on varade kogumuutus 0.480. Käibevara valdkonnas on 000999.SZ aruandlusvaluutas 22522.003. Märkimisväärne osa neist varadest, täpsemalt 8226.787, hoitakse sularahas ja lühiajalistes investeeringutes. See segment näitab eelmise aasta andmetega võrreldes muutust 1.612%. Ettevõtte pikaajalised investeeringud, kuigi need ei ole tema fookuses, seisavad 724.938, kui neid on, aruandlusvaluutas. See näitab erinevust -75.410% võrreldes eelmise aruandeperioodiga, mis kajastab ettevõtte strateegilisi muutusi. Ettevõtte võlaprofiil näitab, et ettevõtte pikaajaline koguvõlg on 1802.932 aruandlusvaluutas. See näitaja tähendab, et aastane muutus on 9.079%. Aktsionäride väärtus, mida näitab aktsionäride kogu omakapital, on hinnatud 18967.142 aruandlusvaluutas. Selle aspekti aastane muutus on 0.115%. Kui süveneda ettevõtte finantsnäitajatesse, ilmneb täiendavaid üksikasju. Netovõlad on hinnatud 8581.24, varude hind on 5112.5 ja firmaväärtus 5123.93, kui see on olemas. Kogu immateriaalne vara, kui see on olemas, hinnatakse 4078.25.

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000	1998
balance-sheet.row.cash-and-short-term-investments	31131.85	8226.8	3149.7	4283.9	4022.4	3045.8	2476.4	1708.4	910.8	973.2	1140	1362	1345.9	2022.6	1731.2	1273.2	718.1	824.6	546.7	363.9	643.6	2246.3	1772.3	1313.9	2294.2	1168.5	76.6	252.6
balance-sheet.row.short-term-investments	4438.4	1873.3	-2647.1	1218.8	200.2	-106.9	-84.8	-77.6	-68.7	-70.2	-61.3	0	-54.3	-31.1	0	0	0	0	0	0	0	0	5	0	0	0	0	0
balance-sheet.row.net-receivables	35661.86	8581.2	6071.3	5659.4	5054.1	5761.2	4512.3	4003.5	2859.3	2461.8	2010.6	2190.9	1944.5	1439.8	1283.2	1345.2	1374.2	5062.1	4743	4777.7	8549.3	6614	2903.8	3821	121.2	414.9	43.7	21.3
balance-sheet.row.inventory	19561.08	5112.5	2498.9	2308.5	1761.6	1432.4	1533.4	1105.2	904.8	910.6	858.3	999.9	823.7	683.5	490.4	418.4	484.3	601.7	407.3	429.7	322.8	372.3	446.1	470.9	520.4	302.8	278.5	283.2
balance-sheet.row.other-current-assets	2087.77	601.5	268.6	226.6	87.1	53.3	54.4	26.6	407.6	867.8	1114.4	622.7	23.7	0.4	0.2	0.4	10	10.1	5.7	5.3	-3940.4	-2807.3	0.1	0.1	1867.9	1256.2	1042.9	669.9
balance-sheet.row.total-current-assets	88442.55	22522	11988.5	12478.4	10925.2	10292.8	8576.5	6843.6	5082.5	5213.3	5123.3	5175.5	4137.9	4146.3	3505	3037.2	2586.5	6498.5	5702.6	5576.6	5575.3	6425.4	5122.3	5605.9	4803.7	3142.3	1441.6	1227
balance-sheet.row.property-plant-equipment-net	26485.4	6802.6	4823	4237.8	3770.7	3611.7	3526.1	3555.8	3272.3	3076.7	2809	2771.4	2436.6	1977.7	1340.2	1352.3	1256.6	1082.1	996	1009.6	1070.9	1028.4	913.4	776.2	799.3	308.2	216.3	206.2
balance-sheet.row.goodwill	20610.44	5123.9	3994.9	4060.4	4104.6	3353.7	3543.9	3549.8	3142.2	1730.7	707.3	581.9	307	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.intangible-assets	16356.23	4078.3	2749.9	2646.6	2586.9	2097.4	2038.9	1965.1	1837.1	1763.5	1611.1	1554.1	1461.4	1319	1161.8	1148.8	1104.6	66.1	55	47.8	52	81.3	83.3	74.4	98.7	35.1	24.8	16.2
balance-sheet.row.goodwill-and-intangible-assets	36966.68	9202.2	6744.7	6707	6691.5	5451.1	5582.8	5514.9	4979.3	3494.2	2318.4	2136	1768.4	1319	1161.8	1148.8	1104.6	66.1	55	47.8	52	81.3	83.3	74.4	98.7	35.1	24.8	16.2
balance-sheet.row.long-term-investments	2002.87	724.9	2948.1	-980.1	-23.8	148.8	132.3	91.1	82.6	92.9	256	0	74.1	50	0	0	0	0	0	0	0	0	660.2	0	0	0	0	0
balance-sheet.row.tax-assets	2492.53	626.8	324.5	241.4	150.3	125.8	109.9	112.1	87	91.1	99.3	75.6	61.9	59.6	47.5	51.8	70.8	70.6	0	0	0	0	72.9	0	0	0	0	0
balance-sheet.row.other-non-current-assets	2569.73	270	293.9	1623.5	496.2	473.4	102.3	77.9	48.1	51	61.2	84	133.6	46.4	36.6	41.4	33	56	301	409.3	479.4	761.1	-1.9	142.5	188.1	93.9	24.1	18.5
balance-sheet.row.total-non-current-assets	70517.2	17626.5	15134.3	11829.6	11084.9	9810.7	9453.4	9351.8	8469.3	6805.9	5543.9	5067	4474.5	3452.7	2586.1	2594.2	2465	1274.9	1352	1466.7	1602.3	1870.9	1728	993.1	1086.1	437.3	265.2	240.9
balance-sheet.row.other-assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-assets	158959.75	40148.5	27122.8	24308	22010.1	20103.5	18029.9	16195.5	13551.7	12019.3	10667.2	10242.5	8612.4	7599	6091.2	5631.4	5051.5	7773.4	7054.6	7043.3	7177.6	8296.2	6850.2	6599.1	5889.9	3579.6	1706.8	1467.9
balance-sheet.row.account-payables	10661.5	2365.2	1795.1	1415.8	1117.6	1027.3	1041.5	1132.1	903.6	924.5	725.7	1033.7	721.3	804.5	606	629.7	713.6	490.9	468.2	540.2	831.5	684.4	790.2	331.1	460.1	403	413	326.4
balance-sheet.row.short-term-debt	6351.27	2019.9	235.1	110.7	30.8	30	35.2	530.1	20.1	0.7	36.9	37	79.1	61.3	43	12	95.5	3103.6	3233	3244.8	3388.9	4032.8	2732.7	2739.3	1824.8	245.7	321.5	361
balance-sheet.row.tax-payables	1709.78	254.5	518.1	373.9	387.7	311.4	293.4	277.1	248.7	211.7	207.9	248.5	222.1	112.7	115.2	131.4	158.4	97	110.1	116.1	124.1	111.5	50	67	26.3	87.3	90.7	79.9
balance-sheet.row.long-term-debt-total	7337.29	1802.9	156	96.7	101.4	10.2	10.2	0.2	499.9	499.7	508.5	501.1	26.3	4.3	2.9	39.5	14.6	15.6	24.7	35.2	60	76.1	21.2	192.3	162.9	17	10	4.9
Deferred Revenue Non Current	2242.3	455.5	423.2	395.1	346.4	355.3	375.4	395.3	384.7	393.6	361	9.8	10.5	3	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.deferred-tax-liabilities-non-current	1527.48	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.other-current-liab	14138.21	6911.7	5630.2	234.5	152.1	22.3	4946.4	448.4	264.9	336.9	228.5	288.6	359.9	200.5	417.5	448.8	328.8	672.7	61.6	128.5	126.4	23.6	31.5	25.6	11.7	20.3	16.1	10.5
balance-sheet.row.total-non-current-liabilities	11689.15	2474.3	916.7	819.8	655.6	528.5	544.9	566.3	1043.4	1043.7	1000.6	865.6	346.7	112.8	54.7	69.9	14.6	15.6	45.4	63	68.1	85.5	28.1	193.7	171.3	36.7	16.1	7.4
balance-sheet.row.other-liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.capital-lease-obligations	494.4	119.5	105.8	88.7	148.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-liab	61904.84	15421.2	9589.4	8595.3	7951.1	7221.6	6861.4	6070.8	4830.4	4345.1	3671.7	3881.5	3036.3	2748.5	1627.4	1679.9	1638.8	4889.9	4509.4	4651	4889.8	5202.4	3948.3	3646.9	2909.6	926	959.7	897.2
balance-sheet.row.preferred-stock	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.common-stock	3952.9	988.2	988.3	978.9	978.9	978.9	978.9	978.9	978.9	978.9	978.9	978.9	978.9	978.9	978.9	978.9	978.9	978.9	978.9	978.9	978.9	978.9	753	753	753	753	694.8	519.2
balance-sheet.row.retained-earnings	62863.05	16047.3	13761.4	12131.5	10581.5	9871.8	8141.1	7154.4	6009.3	4958.3	4176.2	3599.5	2776.4	2063.3	1626	1149.3	694.9	251	-202.7	-365	-484.8	322.8	146.3	76.7	56.7	108.1	0	0
balance-sheet.row.accumulated-other-comprehensive-income-loss	6444.97	754.6	673.1	549.3	543.8	545.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.other-total-stockholders-equity	2509.22	1177	1586.7	1622.9	1622.9	1167.9	1707.7	1705.2	1626.8	1634.4	1604.9	1570.4	1554.5	1502.8	1608.1	1558.1	1526.2	1499.9	1620.7	1618.8	1619.8	1607.6	1799.6	1774.2	1772.8	1714.8	0	0
balance-sheet.row.total-stockholders-equity	75770.14	18967.1	17009.6	15282.5	13727.1	12563.8	10827.7	9838.5	8615	7571.7	6759.9	6148.8	5309.8	4545	4212.9	3686.3	3200	2729.8	2396.8	2232.7	2113.9	2909.3	2698.9	2603.9	2582.5	2575.9	694.8	519.2
balance-sheet.row.total-liabilities-and-stockholders-equity	158959.75	40148.5	27122.8	24308	22010.1	20103.5	18029.9	16195.5	13551.7	12019.3	10667.2	10242.5	8612.4	7599	6091.2	5631.4	5051.5	7773.4	7054.6	7043.3	7177.6	8296.2	6850.2	6599.1	5889.9	3579.6	1706.8	1467.9
balance-sheet.row.minority-interest	20819.42	5294.7	523.8	430.2	331.9	318	340.8	286.2	106.3	102.5	235.6	212.2	266.3	305.6	250.8	265.2	212.6	153.6	148.3	159.6	174	184.5	203.1	348.3	397.7	77.7	52.3	51.5
balance-sheet.row.total-equity	96589.56	24261.9	17533.4	15712.7	14059	12881.9	11168.5	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.total-liabilities-and-total-equity	158959.75	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Investments	6441.27	2598.3	301	238.7	176.3	41.8	47.5	13.5	13.9	22.7	194.6	26.6	19.8	18.9	18.1	17.3	16.2	23.2	275.9	380.9	433.2	697.9	665.2	108.8	112.4	78.6	8.2	7.8
balance-sheet.row.total-debt	13908.27	3942.3	391.1	207.4	30.8	30	35.2	530.3	520	500.4	545.4	538	105.4	65.5	45.9	51.5	110.1	3119.2	3257.7	3280	3448.9	4108.9	2753.9	2931.6	1987.7	262.7	331.5	361
balance-sheet.row.net-debt	-12785.17	-2411.2	-2758.6	-2857.7	-3791.4	-3015.8	-2441.1	-1178.1	-390.9	-472.8	-594.6	-824	-1240.6	-1957.1	-1685.3	-1221.7	-608	2294.6	2711	2916.1	2805.3	1862.6	986.6	1617.6	-306.6	-905.7	254.9	108.4

Rahavoogude aruanne

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. finantsmaastikul on viimase perioodi jooksul toimunud märkimisväärne muutus vabas rahavoos, mis näitab 0.637 nihet. Ettevõte laiendas hiljuti oma aktsiakapitali, emiteerides 0, mis tähistab -0.016 erinevust võrreldes eelmise aastaga. Huvitav on see, et osa ettevõtte aktsiatest, täpsemalt 0, ostis ettevõte ise tagasi. Selle tegevuse tulemusena muutus 0.000 võrreldes eelmise aastaga. Vahepeal on ettevõtte võlgnevused praegu 315.29 aruandlusvaluutas. Ettevõtte investeerimistegevuse tulemusel kasutas ettevõte netosularaha, mis aruandlusvaluutas oli -821735320.000. See on -0.669 nihkumine võrreldes eelmise aastaga. Samal perioodil registreeris ettevõte 853.71, 957.78, -1741.8, mis on olulised ettevõtte investeerimis-ja tagasimaksestrateegiate mõistmiseks. Ettevõtte finantseerimistegevuse tulemusel kasutas ettevõte netorahavahendeid 0.000, kusjuures erinevus võrreldes eelmise aastaga oli 0.000. Lisaks eraldas ettevõte -988.35 aktsionäridele dividendide maksmiseks. Samal ajal tegi ta muid finantsmanöövreid, millele viidatakse kui 3180.15, mis samuti mõjutasid oluliselt tema rahavooge sel perioodil. Need komponendid koos annavad tervikliku pildi ettevõtte finantsseisundist ja strateegilisest lähenemisest rahavoogude juhtimisele.

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000
cash-flows.row.net-income	3065.73	2852.9	2497	2080.8	1617.5	2139.1	1474.9	1326.5	1207.8	1274.7	1072.1	1214.6	1081.1	815.1	859.1	761.6	541.1	284.1	166.6	116.8	-718.8	223	153.4	124.1	205.8	230.5
cash-flows.row.depreciation-and-amortization	54.35	853.7	522.7	476.2	391.5	334.9	349.4	320.4	282.5	233.7	234.8	231.8	224.7	133.6	117.4	105.5	83.1	69	83.6	72.7	90.4	64.2	63.6	52.7	71.6	56.5
cash-flows.row.deferred-income-tax	-74.4	-137.7	-63.5	-87	-21.1	-8.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.stock-based-compensation	82.91	-1724.5	63.5	87	21.1	8.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.change-in-working-capital	-332.32	-17	-216.9	-946.9	72	47	42.6	-150.4	-137.8	-114.7	-147.7	-32	-164.6	-22.6	-42.2	-42.4	456.2	-21.6	-25.4	-518.1	-1084.8	-433.5	98.3	-145.7	-38.5	-304.9
cash-flows.row.account-receivables	633.69	633.7	-71.8	-674.7	620.9	-820.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.inventory	-966.01	-966	-59.7	-664.9	-286.8	87	-436	-144.4	-9.6	-61.1	108.1	-130.1	-135.8	-157.3	-102.8	-54.3	135.8	-188.5	55.5	-101	29	57.2	53	-24.8	-48.7	-22.6
cash-flows.row.account-payables	0	315.3	-21.9	458.4	-241.1	774.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.other-working-capital	0	0	-63.5	-65.7	-21.1	5.7	478.6	-5.9	-128.1	-53.7	-255.7	98.1	-28.8	134.8	60.6	11.9	320.4	166.9	-80.9	-417.1	-1113.8	-490.8	45.4	-120.9	10.1	-282.3
cash-flows.row.other-non-cash-items	1989.6	2393	203.5	260.3	142.9	-549.1	44.4	63.9	39.6	-133.8	25.2	53	70.6	28.7	-86	30.3	35.9	273.8	200.7	351.4	993.5	174.4	180.8	122.3	28	138.6
cash-flows.row.net-cash-provided-by-operating-activities	4707.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.investments-in-property-plant-an-equipment	-780.38	-857.2	-951.6	-870.8	-621.8	-536	-600.4	-374.7	-354.3	-330.6	-341.2	-354.9	-504.5	-409.8	-270	-192.9	-1203.2	-226.8	-135.8	-37.1	-84.6	-135.9	-172.7	-118.8	-170.6	-73.4
cash-flows.row.acquisitions-net	25.56	31.1	-11.8	-120.6	-993.1	73.3	-140.2	-641.2	-1603.6	-1139	-218.8	-479.8	-1136.2	12.2	-7.8	172.9	-65.8	7.3	0.7	13.8	1.3	6.4	26.8	0	5.5	0
cash-flows.row.purchases-of-investments	-4195.27	-3182	-5675.9	-5203.2	-5419.9	-3808.9	-4254.7	-2003	-2530.1	-2514	-2850	-1094.8	0	-5	-12	-79.6	-0.2	-3.6	-7.6	-0.9	-20.1	-150	-22.9	-26.5	-395.7	-467.6
cash-flows.row.sales-maturities-of-investments	2908.42	2228.6	4152.1	4394.8	6285.5	3765.5	4073.4	2420.9	3007.2	3125.6	2380.4	354.2	0	0.1	0.1	0.1	1.4	7.6	42.5	6.7	0.8	13	52.2	0	94.9	0
cash-flows.row.other-investing-activites	-284.8	957.8	8	9.3	90	-5.4	31.1	46	256.6	68.1	110	26.1	98.9	17.5	221.9	6.5	4.8	-11.2	-25.1	18.8	31.4	-812.8	-262.4	-1081.5	-1116.7	-342.1
cash-flows.row.net-cash-used-for-investing-activites	-2326.47	-821.7	-2479.2	-1790.5	-659.3	-511.4	-890.7	-552.1	-1224.2	-789.8	-919.6	-1549.1	-1541.9	-385	-67.8	-93	-1263	-226.7	-125.2	1.3	-71.2	-1079.2	-379	-1226.8	-1582.6	-883.1
cash-flows.row.debt-repayment	-1446.58	-1741.8	-462.2	-28.5	-1251.8	-535.2	-530.2	-92.3	-0.7	-32.6	-23	-116.3	-139.9	-158.9	-13.1	-57.5	-57.3	-216.1	-1475	-1741.8	-2424	-3137.6	-3492.2	-3446.7	-1025.2	-205.7
cash-flows.row.common-stock-issued	0.28	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.common-stock-repurchased	-0.28	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.dividends-paid	-1076.37	-988.3	-855.8	-491.8	-424.4	-384.8	-491.3	-181.6	-170	-423	-290	-276.6	-256.3	-304.6	-295.5	-201.8	-11.7	-14.6	-117.3	-132	-201	-266.2	-223.4	-211	-99.3	-37.2
cash-flows.row.other-financing-activites	3351.22	3180.1	742.5	-132.8	207.6	27.8	588.8	65.4	-53.5	-186.9	-0.9	500.3	74.2	118	51.8	46	90.3	76.5	1470.6	1935.7	2402.5	4551.5	3499.3	4307.2	2326.7	1752.5
cash-flows.row.net-cash-used-provided-by-financing-activities	-97.65	450	-575.5	-653.1	-1468.6	-892.2	-432.6	-208.6	-224.2	-642.5	-313.9	107.3	-321.9	-345.4	-256.8	-213.3	21.3	-154.3	-121.8	62	-222.5	1147.8	-216.3	649.5	1202.2	1509.6
cash-flows.row.effect-of-forex-changes-on-cash	4.94	5	6.3	-2.3	-5.1	1	-0.3	-3.8	2	1.4	-0.2	-1.5	-0.1	-1	-2.3	0	-0.7	-0.4	-0.5	-0.1	0	0	0	0	-0.2	0
cash-flows.row.net-change-in-cash	2101.65	3203.7	-41.9	-575.4	90.9	569.3	587.5	796	-54.3	-171.1	-49.4	24.2	-652.1	223.5	521.4	548.7	-126	224	178	-193.7	-1013.2	96.7	-99.2	-423.8	-113.8	747.1
cash-flows.row.cash-at-end-of-period	25499.51	6353.5	2361.4	2403.2	2978.7	2842.1	2272.8	1685.3	889.3	943.6	1114.7	1343.5	1310.2	1962.3	1687.1	1165.7	616.7	694.9	489.1	674.9	304.4	276.1	179.5	278.7	709.6	1168.5
cash-flows.row.cash-at-beginning-of-period	23397.85	3149.7	2403.4	2978.7	2887.7	2272.8	1685.3	889.3	943.6	1114.7	1164.1	1319.2	1962.3	1738.8	1165.7	617	742.7	470.9	311.1	868.7	1317.6	179.5	278.7	702.5	823.4	421.4
cash-flows.row.operating-cash-flow	4707.2	4220.4	3006.4	1870.5	2224	1971.8	1911.2	1560.4	1392.1	1259.8	1184.4	1467.4	1211.8	954.9	848.3	855.1	1116.4	605.3	425.5	22.8	-719.6	28.1	496.1	153.4	266.9	120.6
cash-flows.row.capital-expenditure	-780.38	-857.2	-951.6	-870.8	-621.8	-536	-600.4	-374.7	-354.3	-330.6	-341.2	-354.9	-504.5	-409.8	-270	-192.9	-1203.2	-226.8	-135.8	-37.1	-84.6	-135.9	-172.7	-118.8	-170.6	-73.4
cash-flows.row.free-cash-flow	3926.82	3363.2	2054.8	999.7	1602.2	1435.9	1310.9	1185.7	1037.8	929.2	843.2	1112.5	707.3	545.1	578.3	662.1	-86.8	378.5	289.7	-14.3	-804.2	-107.8	323.4	34.6	96.3	47.2

Kasumiaruande rida

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. tulud muutusid võrreldes eelmise perioodiga 0.353%. 000999.SZ brutokasum on teatatud 12604.36. Ettevõtte tegevuskulud on 9080.31, mille muutus võrreldes eelmise aastaga on 35.183%. Kulud amortisatsioonikulud on 853.71, mis on 0.213% muutus võrreldes eelmise aruandeperioodiga. Tegevuskulud on teatatud 9080.31, mis näitab 35.183% muutust võrreldes eelmise aastaga. Müügi- ja turunduskulud on 0, mis on 0.000% muutus võrreldes eelmise aastaga. Hiljutistel numbritel põhinev EBITDA on 0, mis tähendab 0.196% kasvu võrreldes eelmise aastaga. Tegevustulu on 3524.05, mis näitab 0.196% muutust võrreldes eelmise aastaga. Puhaskasumi muutus on 0.165%. Eelmise aasta puhaskasum oli 2852.93.

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000	1998
income-statement-row.row.total-revenue	25524.28	24464	18079.5	15320	13637.3	14701.9	13427.7	11119.9	8981.7	7900.2	7276.6	7801.6	6891.1	5525.2	4365.2	4852.7	4316.2	3397.8	2867.9	2969.5	2461.7	2674.5	2165.7	1867.3	1828.1	1476.4	1425.9	1109.8
income-statement-row.row.cost-of-revenue	12125.74	11859.7	8313.1	6170.8	5119.6	4830.1	4160.4	3907.7	3362.3	3067	2812.2	3089.9	2678.2	2267.4	1686.2	2396.1	2352.9	1780.9	1551.4	1559.2	1363.5	1353.9	1103.3	917	1005.3	635.4	604.7	487.2
income-statement-row.row.gross-profit	13398.55	12604.4	9766.3	9149.2	8517.6	9871.8	9267.4	7212.2	5619.5	4833.2	4464.4	4711.7	4212.9	3257.8	2678.9	2456.7	1963.3	1617	1316.5	1410.2	1098.2	1320.6	1062.4	950.3	822.8	841	821.2	622.6
income-statement-row.row.gross-profit-ratio	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.research-development	700.37	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-general-administrative	380.93	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-and-marketing-expenses	7123.52	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-expenses	-161.15	-108.2	792.5	662.2	625.1	678.3	15.4	7.8	175.5	91.9	39.1	25.7	75.4	28.1	74.2	22.2	16.5	59.7	-13.1	8.5	-9.8	4.5	9.2	47.4	59.3	52.2	46.4	45.9
income-statement-row.row.operating-expenses	9498.49	9080.3	6717	6497.6	6337	7907.7	7550.3	5661.1	4291.2	3555.8	3243.7	3291.2	2950.2	2325.7	1759.1	1553.9	1309.5	1051.6	894.4	1036.5	1380.6	909.9	764.4	797.3	616.1	605.2	649.5	474.9
income-statement-row.row.cost-and-expenses	21624.23	20940	15030.2	12668.4	11456.7	12737.8	11710.7	9568.8	7653.4	6622.9	6055.8	6381.1	5628.4	4593.1	3445.4	3949.9	3662.4	2832.4	2445.9	2595.8	2744.1	2263.8	1867.7	1714.3	1621.3	1240.7	1254.2	962.1
income-statement-row.row.interest-income	76.05	106.9	73.5	67	73.7	22.8	31.6	10	12.3	21.9	24.4	29.9	24.2	27.4	18.4	13.1	10.6	18.2	12	44.6	61	65.3	66.5	141.7	78.8	0	0	0
income-statement-row.row.interest-expense	91.89	80.8	21.2	13.3	5.1	4.4	25.8	28	28.2	27.9	27.6	22.6	8.8	10.5	1.8	9.6	14.4	120.8	198.8	204.7	203.5	189.8	172.3	157.6	102.8	25.1	29.4	21.6
income-statement-row.row.selling-and-marketing-expenses	7123.52	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.total-other-income-expensenet	192.28	225.2	16.2	-28.4	-10.8	39.2	1.8	-32.8	124.9	251.7	38.9	12.5	20.1	15.9	114.2	1.7	-7.8	-181	-249.7	-226.4	-417.1	-149.2	-114.5	13.4	34.5	23.6	17.3	-4
income-statement-row.row.ebitda-ratio-caps	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-operating-expenses	-161.15	-108.2	792.5	662.2	625.1	678.3	15.4	7.8	175.5	91.9	39.1	25.7	75.4	28.1	74.2	22.2	16.5	59.7	-13.1	8.5	-9.8	4.5	9.2	47.4	59.3	52.2	46.4	45.9
income-statement-row.row.total-operating-expenses	192.28	225.2	16.2	-28.4	-10.8	39.2	1.8	-32.8	124.9	251.7	38.9	12.5	20.1	15.9	114.2	1.7	-7.8	-181	-249.7	-226.4	-417.1	-149.2	-114.5	13.4	34.5	23.6	17.3	-4
income-statement-row.row.interest-expense	91.89	80.8	21.2	13.3	5.1	4.4	25.8	28	28.2	27.9	27.6	22.6	8.8	10.5	1.8	9.6	14.4	120.8	198.8	204.7	203.5	189.8	172.3	157.6	102.8	25.1	29.4	21.6
income-statement-row.row.depreciation-and-amortization	510.85	853.7	704	729.5	642.6	630.8	349.4	320.4	282.5	233.7	234.8	231.8	224.7	133.6	117.4	105.5	83.1	69	83.6	72.7	90.4	64.2	63.6	52.7	71.6	56.5	27.8	78.2
income-statement-row.row.ebitda-caps	4353.5	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.operating-income	3856.84	3524	2947.2	2457.4	2070.2	2529.4	1703.5	1510.5	1293.7	1442.6	1228	1411.8	1262.1	926.8	962.6	885	635	325.6	258.1	193.3	-649.8	279.8	185.7	126.7	196.2	208.3	143.2	98.5
income-statement-row.row.income-before-tax	4049.12	3749.2	2963.4	2429.1	2059.4	2568.6	1718.9	1518.3	1453.2	1529	1259.6	1433	1282.8	948.1	1034	904.5	646	384.4	208.7	174.5	-679.5	272.9	189.2	170.3	248.4	259.9	189.3	144.1
income-statement-row.row.income-tax-expense	650.56	581	466.4	348.2	441.9	429.5	244	191.8	245.4	254.3	187.5	218.3	201.7	133	174.9	142.9	104.9	100.3	42.1	59.9	39.3	49.8	35.8	46.1	42.7	29.5	30.2	28.6
income-statement-row.row.net-income	3065.73	2852.9	2448.8	2055.1	1597.5	2112.5	1432.1	1301.7	1197.8	1249.2	1035.9	1181.1	1014.1	760.4	816	709.5	500.1	279.8	164.9	119.9	-720.8	208.8	165	121	201.6	220.2	150.8	98.8